The president has persuaded U.S.-based companies to take action. President Donald Trump recently struck a deal with nine U.S. pharmaceutical companies, which will decrease prices for a large…
Read MoreMost Favored Nation Pricing
CMS Launches Initiative to Control Drug Costs and Strengthen Medicaid Access
The new GENEROUS Model is intended to align Medicaid prescription prices with global standards. The Centers for Medicare & Medicaid Services (CMS) introduced a pilot program, the GENEROUS…
Read More